Live Oak Private Wealth’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Live Oak Private Wealth's NVS Position: Q3 2026 in Review
Live Oak Private Wealth reduced its Novartis (NVS) stake by 0.43% in Q3 2026, selling an estimated $46.9K and leaving 72,117 shares worth $10.3M. The position accounts for 1.24% of the portfolio, ranked #25.
Live Oak Private Wealth first reported a position in NVS in Q1 2020 and has held it in 27 quarters since. The position peaked at $11.5M in Q1 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Live Oak Private Wealth held 72,117 shares of Novartis worth $10.3M as of Q3 2026.
- Live Oak Private Wealth sold 309 Novartis shares in Q3 2026, an estimated $46.9K.
- Novartis made up 1.24% of Live Oak Private Wealth's portfolio in Q3 2026, its #25 holding.
- Live Oak Private Wealth first reported a position in Novartis in Q1 2020 and has held it in 27 quarters since.
- Live Oak Private Wealth's Novartis position peaked at $11.5M in Q1 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Live Oak Private Wealth's 13F filing for Q3 2026, filed 2 Nov 2026.